Changcheng G. Zheng
No. 17 Lujiang Road
Hefei, 230001, China
Hefei, 230001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Superior Efficacy and Deep Molecular Remission with Venetoclax Plus Hypomethylating Agent in Elderly Acute Myeloid Leukemia: A Real-World Comparative Cohort Study.
Journal: Clinical pharmacology : advances and applications
Published: January 18, 2026
Venetoclax Plus Hypomethylating Agents for Treatment-Naïve Myelodysplastic Syndromes with Increased Blasts: A Prospective Multicenter Cohort Study.
Journal: Blood and lymphatic cancer : targets and therapy
Published: December 29, 2025
Development and Validation of a Novel Thrombosis Prediction Model for Adult Immune Thrombocytopenia (ITP-THROMBO).
Journal: Journal of blood medicine
Published: October 01, 2025
Chinese guidance for the clinical application of adeno-associated virus vector-based gene therapy for hemophilia B (2025).
Journal: Blood science (Baltimore, Md.)
Published: May 22, 2025
Adoptive transfer of third-party donor CMV-specific T cells for refractory cytomegalovirus infection following umbilical cord blood transplantation.
Journal: British journal of haematology
Published: March 20, 2025
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials.
Journal: Nature medicine
Published: March 02, 2025
Reduced-Dose versus Standard-Dose Emicizumab for Haemophilia A: A Retrospective Cohort Study.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: February 28, 2025
Targeting leukemic stem cell biomechanics suppresses stemness and enhances NK cell-mediated immunotherapy.
Journal: Nature communications
Published: January 10, 2025
Real-World Analysis of Clinical Characteristics, Treatment Outcomes, and the Novel Predictive Model for Patients with Thrombotic Thrombocytopenic Purpura (TTP) and TTP-Like Syndrome.
Journal: Vascular health and risk management
Published: November 26, 2024
Successfully treatment of PLZF-RARα positive acute promyelocytic leukemia by Venetoclax combining with decitabine: a case report and literature review.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 16, 2024
Safety and infection risk factors in elderly acute myeloid leukemia patients undergoing induction therapy with venetoclax combined with hypomethylating agents.
Journal: American journal of cancer research
Published: August 27, 2024
Last Updated: 09/26/2026